A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging

Brain

Volumn 138, Issue 4, 2015, Pages 932-945

  Mainero, Caterina ^a,b   Louapre, Céline ^a,b   Govindarajan, Sindhuja T ^a   Gianni, Costanza ^a,b   Scott Nielsen, A ^b,c,d   Cohen Adad, Julien ^a,e   Sloane, Jacob ^b,c   Kinkel, Revere P ^b,c,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

7 T MRI; gyri; multiple sclerosis; quantitative T2; subpial demyelination; sulci

Indexed keywords

IRON; MYELIN;

ADULT; ARTICLE; BRAIN CORTEX LESION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); FEMALE; GRAY MATTER; HUMAN; IN VIVO STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SPATIAL ANALYSIS; SURFACE PROPERTY; WHITE MATTER LESION; BRAIN CORTEX; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; STANDARDS;

ADULT; CEREBRAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES;

EID: 84929074022     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv011     Document Type: Article

References (47)

1. Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain 2011; 134 (Pt 12): 3602-15.
2. Bo L, Geurts JJ, van der Valk P, Polman C, Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007; 64: 76-80.
3. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003a; 9: 323-31.
4. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demye-lination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003b; 62: 723-32.
5. Cohen-Adad J, Benner T, Greve D, Kinkel RP, Radding A, Fischl B, et al. In vivo evidence of disseminated subpial T2∗ signal changes in multiple sclerosis at 7T: a surface-based analysis. Neuroimage 2011; 57: 55-62.
6. Cohen-Adad J, Polimeni JR, Helmer KG, Benner T, McNab JA, Wald LL, et al. T2∗ mapping and B0 orientation-dependence at 7 T reveal cyto-and myeloarchitecture organization of the human cortex. Neuroimage 2012; 60: 1006-14.
7. Connor JR, Menzies SL. Altered cellular distribution of iron in the central nervous system of myelin deficient rats. Neuroscience 1990; 34: 265-71.
8. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179-94.
9. Debernard L, Melzer TR, Van Stockum S, Graham C, Wheeler-Kingshott CA, Dalrymple-Alford JC, et al. Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatr 2014; 85: 544-51.
10. Deistung A, Schafer A, Schweser F, Biedermann U, Turner R, Reichenbach JR. Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2∗-imaging at ultra-high magnetic field strength. NeuroImage 2013; 65: 299-314.
11. Derakhshan M, Caramanos Z, Narayanan S, Arnold DL, Louis Collins D. Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination. Hum Brain Mapp 2014; 7: 3402-13.
12. Dortch RD, Moore J, Li K, Jankiewicz M, Gochberg DF, Hirtle JA, et al. Quantitative magnetization transfer imaging of human brain at 7 T. NeuroImage 2013; 64: 640-9.
13. Filippi M, Evangelou N, Kangarlu A, Inglese M, Mainero C, Horsfield MA, et al. Ultra-high-field MR imaging in multiple sclerosis. J Neurol Neurosurg Psychiatr 2014; 85: 60-6.
14. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 97: 11050-5.
15. Fukunaga M, Li TQ, van Gelderen P, de Zwart JA, Shmueli K, Yao B, et al. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci USA 2010; 107: 3834-9.
16. Geurts JJ, Calabrese M, Fisher E, Rudick RA. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol 2012; 11: 1082-92.
17. Govindarajan ST, Cohen-Adad J, Sormani MP, Fan AP, Louapre C, Mainero C. Reproducibility of T2∗ mapping in the human cerebral cortex in vivo at 7 Tesla MRI. J Magn Reson Imaging 2014. Advance Access published on November 19, 2014, doi: 10.1002/jmri.24789.
18. Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009; 48: 63-72.
19. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magnetic resonance imaging 2005; 23: 1-25.
20. Hagler DJ Jr, Saygin AP, Sereno MI. Smoothing and cluster thresholding for cortical surface-based group analysis of fMRI data. Neuroimage 2006; 33: 1093-103.
21. Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 2011; 134 (Pt 9): 2755-71.
22. Klaver R, De Vries HE, Schenk GJ, Geurts JJ. Grey matter damage in multiple sclerosis: a pathology perspective. Prion 2013; 7: 66-75.
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
24. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci 2006; 245: 123-6.
25. Langkammer C, Krebs N, Goessler W, Scheurer E, Ebner F, Yen K, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology 2010; 257: 455-62.
26. Lassmann H, Lucchinetti CF. Cortical demyelination in CNS inflammatory demyelinating diseases. Neurology 2008; 70: 332-3.
27. Li W, Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. NeuroImage 2011; 55: 1645-56.
28. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 1996; 46: 907-11.
29. Lublin FD. New multiple sclerosis phenotypic classification. Eur Neurol 2014; 72 ((Suppl 1): 1-5.
30. Lucchinetti CF, Popescu BF, Bunyan RF, Moll NM, Roemer SF, Lassmann H, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011; 365: 2188-97.
31. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130 (Pt 4): 1089-104.
32. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-93.
33. Mainero C, Benner T, Radding A, van der Kouwe A, Jensen R, Rosen BR, et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 2009; 73: 941-8.
34. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
35. Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C. Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 2013; 81: 641-9.
36. Peruzzo D, Castellaro M, Calabrese M, Veronese E, Rinaldi F, Bernardi V, et al. Heterogeneity of cortical lesions in multiple sclerosis: an MRI perfusion study. J Cereb Blood Flow Metab 2013; 33: 457-63.
37. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
38. Pitt D, Boster A, Pei W, Wohleb E, Jasne A, Zachariah CR, et al. Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 2010; 67: 812-8.
39. Reich D, Rao A, Vuolo L, Absinta M, Nair G, Butman J, et al. Leptomeningeal contrast enhancement: a possible marker of inflammation in the subarachnoid space. Proc Am Acad Neurol 2014.
40. Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O. The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathologica 2011; 122: 155-70.
41. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-51.
42. Samson RS, Muhlert N, Sethi V, Wheeler-Kingshott CAM, Ron MA, Miller DH, et al. Sulcal and gyral crown cortical grey matter involvement in multiple sclerosis: a magnetisation transfer ratio study. Mult Scler Relat Disord 2013; 2: 204-12.
43. Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, et al. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups. Mult Scler 2014; 20: 1322-30.
44. Seewann A, Vrenken H, Kooi EJ, van der Valk P, Knol DL, Polman CH, et al. Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis. Mult Scler 2011; 17: 1202-10.
45. Waehnert MD, Dinse J, Weiss M, Streicher MN, Waehnert P, Geyer S, et al. Anatomically motivated modeling of cortical laminae. Neuroimage 2014; 93 (Pt 2): 210-20.
46. Yao B, Bagnato F, Matsuura E, Merkle H, van Gelderen P, Cantor FK, et al. Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging. Radiology 2012; 262: 206-15.
47. Yao B, Hametner S, van Gelderen P, Merkle H, Chen C, Lassmann H, et al. 7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PloS One 2014; 9: e108863.